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The histological score of the 0.24% gradient collagen was the
best of all experimental conditions. The signiﬁcant differences
existed between the 0.18% gradient collagen and the 0.24%
gradient collagen at 4th and 8th postoperative week (p<0.05).
In the 0.24% gradient collagen, type II collagen was strongly
and widely stained in both the regions, and type I collagen was
weakly stained in the central region.
In vitro haptotactic manner,the 30 times gradient generated the
most effective migration activity for the cultured MSCs.
Conclusions: Concentration-gradient collagen scaffold recruits
effectively the progenitor cells to the center of full-thickness
cartilage defect and enhances regeneration of the full-thickness
cartilage defect. In vitro migration assay suggest that there is
an optimal gradient when using the gradient collagen cylinder to
augment regeneration of full-thickness cartilage defect.
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Purpose: To investigate the effect of using cancellous bone
matrix gelatin (BMG) seeded with allogeneic chondrocytes for
repairing full-thickness articular cartilage defects in rabbits.
Methods: 1 month old rabbit chondrocytes were isolated and
expanded in vitro by monolayer culture. Passage - 1 allogenic
chondrocytes were seeded onto prefabricated cancellous BMG
scaffolds to construct tissue-engineered cartilage grafts and cul-
tured in vitro for 2 weeks. These grafts were then implanted
to repair mature rabbit knee joint osteochondral defects. As a
“Control”, replicate defects were ﬁlled with cancellous BMG only.
After 1 year the treated defect and adjacent sites were harvested
and evaluated for macroscopic tissue morphology, Haematoxylin
and Eosin (HE), Toluidine Blue (TB) and Picricsirius Red staining
as well as immunohistochemistry for typeIIcollagen expression.
Results: After 2 weeks, the allogenic chondrocytes attached
to the cancellous BMG, formed a cartilagenous tissue graft of
5-8 cell layers on the surface of the BMG and secreted ma-
trix proteoglycans and collagen type II. Following 1 year after
the transplant operation, histological staining of the defect site
tissue revealed that reparative tissue had integrated well into
the host cartilage and reconstructed the damaged subchondral
bone plate in all defects where the BMG-allogenic chondrocyte
grafts had been implanted. These defects were fully ﬁlled with
hyaline-like cartilage in this group with cells located in lacuna
and arranged in columns in the deeper zones of the repair tis-
sue. Matrix staining showed the presence of proteoglycans and
collagen type II evenly distributed and well-integrated within the
adjacent articular cartilage. In contrast, in the defects that were
ﬁlled with BMG scaffold alone, these mainly formed a ﬁbrocar-
tilagenous repair tissue with irregularly distributed chondrocytes
and reduced staining for matrix proteoglycans and collagen type
II.
Conclusions: Cancellous BMG is an effective scaffold for use
in cartilage tissue engineering procedures. Cancellous BMG
seeded with allogenic chondrocytes was successful in producing
well-integrated hyaline-like cartilage repair tissue after trans-
plantation for 1 year and this method shows great promise for
treatment of joint osteochondral defects in human patients.
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Purpose: Embryonic stem cells (ESCs) are a promising repar-
ative source for cartilage injury and degenerative joint diseases.
Generally, ESCs are differentiated in the form of an embryoid
body (EB), a stem cell aggregate contains progenitor cells for
all three germ layers of embryo. The EB contains elements of
chondrogenesis. Therefore, under a suitable condition, chon-
drogenesis should occur in EBs. However, most of the current
studies involving chondrogenesis of stem cells are using cells
that are derived from EBs (EBd cells).
Methods: This study was to investigate, at a similar differentia-
tion stage, whether EBs and EBd cells have similar potentials of
chondrogenesis. Mouse embryonic stem cells were cultured in
suspension for EB formation. EBs were obtained at day 5 of EB
culture. EBd cells were cells from collagenase-dissociated EBs.
EBs and EBd cells were centrifuged for pellet formation. Both
EB and EBd cell pellets were cultured in chondrogenic medium
for 3 weeks. The pellets were sampled at weeks 1, 2 and 3 for
histology and immunohistochemistry.
Results: There was a signiﬁcant amount of cell death in both
pellets of EBs and EBd cells after one week in culture. Type II
collagen was positively stained in the EBd cell pellets, but not
in EB pellets. More type II collagen staining was observed at
the peripheral area of the EBd cell pellets. EBd cell pellets were
also stained with aggrecan. Both EB and EBd cell pellets were
stained with type I collagen.
Conclusions: This study shows that dissociation of EBs is
required for chondrogenesis in pellet culture. The dissociation
process allows cells to reorganize in the pellets and respond to
the chondrogenic medium. The chondrogenic process in chon-
drogenic medium is also a process of cell selection as EBs
and EBd cells are heterogenic cell population. Signiﬁcant cell
death in both types of pellets is evident in that only a fraction
of EBd cells have the potential of chondrogenesis. However, this
fraction of cells in EBs did not respond to the current chon-
drogenic condition, indicating the importance of an extracellular
microenvironment in stem cell differentiation.
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Purpose: Autologous chondrocytes transplantation (ACI) has
becoming a more diffuse therapeutical strategy in the repair of
damaged cartilage in clinical practice. The data obtained at long-
term follow-up showed good clinical results together with the
formation of a new tissue with many hyaline features even if long
time is required for a complete regeneration. The improvement
of the technique is mainly due to the use of suitable scaffolds
able to ﬁx the cells into the defect site permitting their prolifer-
ation, maintainance of the chondrocyte phenotype and a easier
surgical procedure. However, until now the indication for ACI are
symptomatic full-thickness chondral injuries or osteochondritis
dissecans and the treatment requires the harvest of healthy car-
tilage tissue and a cell expansion phase in vitro. In order to ﬁnd a
new approach to treat patients with osteoarthritis (OA) suffering
for early degenerative lesions to hyaline cartilage, the aim of
